Pilot Neoadjuvant Trial with Combination of Lapatinib and Nab-Paclitaxel in HER2+Breast Cancer

被引：0
|
作者：
Kaklamani, V [1 ]
Uthe, R. [1 ]
Khan, S. [1 ]
Hansen, N. [1 ]
Bethke, K. [1 ]
Jeruss, J. [1 ]
Cianfrocca, M. [1 ]
Von Roenn, J. [1 ]
Rosen, S. [1 ]
Gradishar, W. [1 ]
机构：
[1] Northwestern Univ, Chicago, IL 60611 USA
来源：
CANCER RESEARCH | 2009年 / 69卷 / 24期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：568S / 568S
页数：1
相关论文
共 50 条
  • [41] nab-Paclitaxel for the Treatment of Aggressive Metastatic Breast Cancer
    Glueck, Stefan
    CLINICAL BREAST CANCER, 2014, 14 (04) : 221 - 227
  • [42] Neoadjuvant pyrotinib versus pertuzumab in combination with trastuzumab and nab-Paclitaxel for patients with HER2-positive early or locally advanced breast cancer (Pyramid): A randomized, multicenter, open-label, phase 2 trial
    Zhang, Jin
    Liu, Qiang
    Jiang, Hongchuan
    Zhang, Jianguo
    Ou, Jianghua
    Chen, Dedian
    Tian, Fuguo
    Li, Yongqing
    Cheng, Xiaoming
    Ouyang, Zhong
    CANCER RESEARCH, 2022, 82 (04)
  • [43] Atezolizumab (in Combination with Nab-Paclitaxel): A Review in Advanced Triple-Negative Breast Cancer
    Kang, Connie
    Syed, Yahiya Y.
    DRUGS, 2020, 80 (06) : 601 - 607
  • [44] Atezolizumab (in Combination with Nab-Paclitaxel): A Review in Advanced Triple-Negative Breast Cancer
    Connie Kang
    Yahiya Y. Syed
    Drugs, 2020, 80 : 601 - 607
  • [45] Phase II Study of Neoadjuvant Weekly nab-Paclitaxel and Carboplatin, With Bevacizumab and Trastuzumab, As Treatment For Women With Locally Advanced HER2+ Breast Cancer
    Yardley, Denise A.
    Raefsky, Eric
    Castillo, Raul
    Lahiry, Anup
    LoCicero, Richard
    Thompson, Dana
    Shastry, Mythili
    Burris, Howard A., III
    Hainsworth, John D.
    CLINICAL BREAST CANCER, 2011, 11 (05) : 297 - 305
  • [46] Pilot study of carboplatin, nab-paclitaxel and pembrolizumab for metastatic triple-negative breast cancer (ongoing clinical trial)
    Baar, J.
    Abraham, J.
    Silverman, P.
    Budd, G. T.
    Vinayak, S.
    Varadan, V.
    Moore, H.
    Montero, A.
    Fu, P.
    CANCER RESEARCH, 2017, 77
  • [47] Topical Imiquimod Plus Nab-paclitaxel for Breast Cancer Cutaneous Metastases A Phase 2 Clinical Trial
    Salazar, Lupe G.
    Lu, Hailing
    Reichow, Jessica L.
    Childs, Jennifer S.
    Coveler, Andrew L.
    Higgins, Doreen M.
    Waisman, James
    Allison, Kimberly H.
    Dang, Yushe
    Disis, Mary L.
    JAMA ONCOLOGY, 2017, 3 (07) : 969 - 973
  • [48] A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2+Breast Cancer
    Veeraraghavan, Jamunarani
    Gutierrez, Carolina
    De Angelis, Carmine
    Davis, Robert
    Wang, Tao
    Pascual, Tomas
    Selenica, Pier
    Sanchez, Katherine
    Nitta, Hiroaki
    Kapadia, Monesh
    Pavlick, Anne C.
    Galvan, Patricia
    Rexer, Brent
    Forero-Torres, Andres
    Nanda, Rita
    Storniolo, Anna M.
    Krop, Ian E.
    Goetz, Matthew P.
    Nangia, Julie R.
    Wolff, Antonio C.
    Weigelt, Britta
    Reis-Filho, Jorge S.
    Hilsenbeck, Susan G.
    Prat, Aleix
    Osborne, C. Kent
    Schiff, Rachel
    Rimawi, Mothaffar F.
    CLINICAL CANCER RESEARCH, 2023, 29 (16) : 3101 - 3109
  • [49] Comparing Neoadjuvant Nab-paclitaxel vs Paclitaxel Both Followed by Anthracycline Regimens in Women With ERBB2/HER2-Negative Breast Cancer-The Evaluating Treatment With Neoadjuvant Abraxane (ETNA) Trial A Randomized Phase 3 Clinical Trial
    Gianni, Luca
    Mansutti, Mauro
    Anton, Antonio
    Calvo, Lourdes
    Bisagni, Giancarlo
    Bermejo, Begona
    Semiglazov, Vladimir
    Thill, Marc
    Ignacio Chacon, Jose
    Chan, Arlene
    Morales, Serafin
    Alvarez, Isabel
    Plazaola, Arrate
    Zambetti, Milvia
    Redfern, Andrew D.
    Dittrich, Christian
    Dent, Rebecca Alexandra
    Magazzu, Domenico
    De Fato, Raffaella
    Valagussa, Pinuccia
    Tusquets, Ignacio
    JAMA ONCOLOGY, 2018, 4 (03) : 302 - 308
  • [50] Combined lapatinib and paclitaxel in HER2-positive breast cancer
    Castaneda, Carlos A.
    Gomez, Henry L.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2009, 6 (06) : 308 - 309
12345